Canadians of South Asian descent are more likely to be diagnosed with breast cancer only at later stages, study says.
Researchers propose that blocking a gene called ID4 could make triple-negative breast cancers more responsive to treatment.
Mutations in CHEK2, rather than the more well-known BRCA genes, are more common in Chinese breast cancer patients.
The gene RASAL2 could help identify triple negative breast cancers and inform treatment options for the aggressive disease.
Australian researchers have unearthed insights into the genetic mechanisms that cause breast cancer.
Reducing the levels of the gene DP103 could help shrink tumors and make patients more amenable to chemotherapy.
Scientists have pinpointed three genetic regions associated with an increased risk of breast cancer in East Asians.
The identification of MED12, found in 60 percent of fibroadenoma patients, could lead to better diagnosis of the common breast tumor.
The Breast Cancer Cell Bank will help to identify new drugs and enhance treatment options for breast cancer patients.